Qube Research & Technologies LTD Amneal Pharmaceuticals, Inc. Transaction History

Qube Research & Technologies LTD

$62.3 Billion
Q2 2024

A detailed history of Qube Research & Technologies LTD transactions in Amneal Pharmaceuticals, Inc. stock. As of the latest transaction made, Qube Research & Technologies LTD holds 640,907 shares of AMRX stock, worth $5.9 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

640,907

Previous 490,874 30.56%

Holding current value

$5.9 Million

Previous $2.97 Million 36.82%

% of portfolio

0.01%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$5.36 - $7.11 $804,176 - $1.07 Million	150,033 Added 30.56%	640,907 $4.07 Million
Q1 2024 May 14, 2024	BUY	$5.24 - $6.34 $2.46 Million - $2.98 Million	470,323 Added 2288.57%	490,874 $2.97 Million
Q4 2023 Feb 13, 2024	BUY	$3.36 - $6.21 $69,051 - $127,621	20,551 New	20,551 $124,000
Q1 2023 May 15, 2023	BUY	$1.27 - $2.7 $52,970 - $112,614	41,709 Added 132.17%	73,265 $101,000
Q4 2022 Feb 14, 2023	BUY	$1.96 - $2.61 $61,849 - $82,361	31,556 New	31,556 $62,000
Q3 2021 Nov 12, 2021	SELL	$4.31 - $5.64 $149,901 - $196,159	-34,780 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$5.12 - $6.82 $153,139 - $203,986	-29,910 Reduced 46.24%	34,780 $178,000
Q1 2021 May 14, 2021	BUY	$4.74 - $7.38 $306,630 - $477,412	64,690 New	64,690 $435,000
Q4 2020 Feb 16, 2021	SELL	$3.95 - $5.42 $98,165 - $134,697	-24,852 Closed	0 $0
Q3 2020 Nov 12, 2020	SELL	$3.54 - $5.27 $356,591 - $530,857	-100,732 Reduced 80.21%	24,852 $96,000
Q2 2020 Aug 14, 2020	BUY	$2.87 - $5.46 $360,426 - $685,688	125,584 New	125,584 $598,000
Q1 2020 May 15, 2020	SELL	$2.46 - $5.35 $100,493 - $218,552	-40,851 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$2.65 - $5.56 $108,255 - $227,131	40,851 New	40,851 $197,000

Others Institutions Holding AMRX

# of Institutions

186

Shares Held

140M

Call Options Held

234K

Put Options Held

45.9K

View Full List

About Amneal Pharmaceuticals, Inc.

Ticker AMRX
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 151,408,992
Market Cap $1.39B
Description
Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...

More about AMRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.

Account

Qube Research & Technologies LTD Amneal Pharmaceuticals, Inc. Transaction History